New Covenant Trust Company’s Bio-Techne TECH Stock Holding History

New Covenant Trust Company’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-39	Closed	-$2.75K	–	367
2024 Q1	$2.75K	Buy	+39	New	+$2.79K	﹤0.01%	392

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return

New Covenant Trust Company's TECH Position: Q2 2024 in Review

New Covenant Trust Company sold out of Bio-Techne (TECH) in Q2 2024, closing a stake of 39 shares — an estimated $2.75K sold.

New Covenant Trust Company first reported a position in TECH in Q1 2024 and held it in 1 quarter. The position peaked at $2.75K in Q1 2024. 572 funds tracked by Wall St. Rank hold TECH as of Q2 2024.

New Covenant Trust Company reported no remaining Bio-Techne position as of Q2 2024 after selling out during the quarter.
New Covenant Trust Company sold 39 Bio-Techne shares in Q2 2024, an estimated $2.75K.
New Covenant Trust Company first reported a position in Bio-Techne in Q1 2024 and held it in 1 quarter.
New Covenant Trust Company's Bio-Techne position peaked at $2.75K in Q1 2024.
572 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2024.

Based on New Covenant Trust Company's 13F filing for Q2 2024, filed 30 Jul 2024.